...
首页> 外文期刊>Molecular medicine reports >Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD+ red blood cells to escape alloanti-RhD immunological recognition
【24h】

Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD+ red blood cells to escape alloanti-RhD immunological recognition

机译:单阵DNA适体掩盖人RHD +红细胞上的RHD抗原表位,以逃避Alloanti-RHD免疫识别

获取原文
获取原文并翻译 | 示例
           

摘要

Rhesus D- (RhD-) individuals should receive Rh-matched blood to prevent hemolytic anemia. However, there is a shortage of RhD- blood. This study aimed to generate RhD antigen-specific single-stranded DNA (ssDNA) aptamers, and test their efficacy in masking RhD antigens on RhD+ red blood cells (RBCs) to prevent their immunoreactivity in vitro. In the present study, ssDNA aptamer candidates were synthesized as a central randomized sequence of 40 nucleotides (nt) flanked by 21-nt primer hybridization sequences. The functional aptamers were screened using the cell-based systematic evolution of ligands by exponential enrichment technique and RhD+ RBCs. Two bioactive ssDNA aptamers significantly inhibited the binding of an anti-RhD antibody to RhD+ RBCs and bound to RhD antigens with high affinity (dissociation constant values of 580.5 +/- 142.0 and 737.7 +/- 161.8 nM, respectively). Furthermore, treatment with both ssDNA aptamers (500 pmol) effectively masked RhD antigens on 4,000,000 RhD+ RBCs to prevent human anti-RhD alloantibody-mediated binding, RBC agglutination and monocyte recognition in vitro. Collectively, such data suggested that these ssDNA aptamers may be feasible for masking RhD antigens on RBCs, and thus valuable for prevention or at least amelioration of RhD+-related hemolytic anemia in RhD- individuals.
机译:恒河猴(RHD-)个体应接受RH匹配的血液以防止溶血性贫血。但是,rhd-血液缺乏。该研究旨在产生rhD抗原特异性单链DNA(SSDNA)适体,并在掩蔽RHD +红细胞(RBC)上的灭耳抗原中的功效测试它们以防止其体外的免疫反应性。在本研究中,将SSDNA适体候选候选被合成为由21-NT引物杂交序列侧翼的40个核苷酸(NT)的中央随机序列。使用指数富集技术和RHD + RBC,使用基于细胞的系统演化筛选功能性适体。两种生物活性SSDNA适体显着抑制抗RHD抗体与RHD + RBC的结合,并与高亲和力的RHD抗原结合(分离常数为580.5 +/- 142.0和737.7 +/- 161.8nm)。此外,用SSDNA适体(500pmol)治疗在4,000,000 rHD + RBC上有效掩盖RHD抗原,以防止人抗RHD Alloantibody介导的结合,RBC凝集和体外单核细胞识别。统称,这种数据表明,这些SSDNA适体对于掩蔽RBC上的RHD抗原可能是可行的,因此对RHD患者的RHD +相关溶血性贫血的有价值或至少改善rhD +相关的溶血性贫血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号